new HIV drug, Selzentry (maraviroc)

September 2007

You'll hear about a new HIV drug, Selzentry (maraviroc).

It's the first in a new class called CCR5 antagonists.

These bind to a receptor called CCR5 on white blood cells...to keep the HIV virus from entering the cell.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

More patients should now get vaccines for meningitis, hepatitis A, varicella, pertussis, and influenza
Osteoporosis Reclast, the first once-a-YEAR bisphosphonate infusion for postmenopausal osteoporosis
ADHD Some Daytrana (methylphenidate) patches are falling off
Infectious Diseases new HIV drug, Selzentry (maraviroc)
Gastroenterology Prilosec and Nexium might cause heart problems
Gastroenterology Zelnorm (tegaserod) is back, but only for certain patients
Geriatrics misuse of the Beers criteria to determine drug therapy in the elderly
Psychiatry Exelon (rivastigmine) now comes in a once-daily PATCH
Ophthalmology eyedrop called AzaSite for bacterial conjunctivitis, or "pink eye"
Respiratory Allergy new Rx antihistamine called Xyzal (ZEYE-zol)
Respiratory Allergy Zyflo CR, a new extended-release version of zileuton for chronic asthma
Diabetes whether patients with type 2 diabetes benefit from monitoring their blood glucose
Diabetes how to treat diabetes during pregnancy
new requirement to use tamper-resistant pads for most written Medicaid prescriptions